Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis.
A randomised, double-blind, placebo-controlled trial with lithium succinate ointment was conducted in patients with AIDS-associated facial seborrhoeic dermatitis. Twice daily applications of the ointment brought about a rapid (2.5 days) and highly significant (P = 0.007) improvement in the severity of the condition. Lithium succinate ointment is well tolerated and can be a useful treatment for seborrhoeic dermatitis in this group of patients.
Langtry
J A
JA
Department of Dermatology, Westminster Hospital, London, UK.
Rowland Payne
C M
CM
Staughton
R C
RC
Stewart
J C
JC
Horrobin
D F
DF
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D012628:Dermatitis, Seborrheic / Q000188:drug therapy* / Q000209:etiology; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D005148:Facial Dermatoses / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D018020:Lithium Compounds / Q000627:therapeutic use*; D008297:Male; D009824:Ointments; D016896:Treatment Outcome
D003879:Dermatologic Agents; D018020:Lithium Compounds; D009824:Ointments